rs2291101

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001289080.2(CNTN6):​c.2259G>A​(p.Val753Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.435 in 1,613,376 control chromosomes in the GnomAD database, including 155,730 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.42 ( 13691 hom., cov: 32)
Exomes 𝑓: 0.44 ( 142039 hom. )

Consequence

CNTN6
NM_001289080.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.27

Publications

18 publications found
Variant links:
Genes affected
CNTN6 (HGNC:2176): (contactin 6) The protein encoded by this gene is a member of the immunoglobulin superfamily. It is a glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein that functions as a cell adhesion molecule. It may play a role in the formation of axon connections in the developing nervous system. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
CNTN6 Gene-Disease associations (from GenCC):
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 3-1383034-G-A is Benign according to our data. Variant chr3-1383034-G-A is described in ClinVar as Benign. ClinVar VariationId is 402550.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.27 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.623 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTN6NM_001289080.2 linkc.2259G>A p.Val753Val synonymous_variant Exon 18 of 23 ENST00000446702.7 NP_001276009.1 Q9UQ52A1LMA8B4DGV0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTN6ENST00000446702.7 linkc.2259G>A p.Val753Val synonymous_variant Exon 18 of 23 1 NM_001289080.2 ENSP00000407822.2 Q9UQ52
CNTN6ENST00000350110.2 linkc.2259G>A p.Val753Val synonymous_variant Exon 18 of 23 1 ENSP00000341882.2 Q9UQ52
CNTN6ENST00000397479.6 linkn.*2397G>A non_coding_transcript_exon_variant Exon 17 of 22 2 ENSP00000380616.2 F8VWS7
CNTN6ENST00000397479.6 linkn.*2397G>A 3_prime_UTR_variant Exon 17 of 22 2 ENSP00000380616.2 F8VWS7

Frequencies

GnomAD3 genomes
AF:
0.418
AC:
63444
AN:
151888
Hom.:
13675
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.374
Gnomad AMI
AF:
0.448
Gnomad AMR
AF:
0.502
Gnomad ASJ
AF:
0.414
Gnomad EAS
AF:
0.641
Gnomad SAS
AF:
0.517
Gnomad FIN
AF:
0.291
Gnomad MID
AF:
0.408
Gnomad NFE
AF:
0.421
Gnomad OTH
AF:
0.418
GnomAD2 exomes
AF:
0.450
AC:
113114
AN:
251386
AF XY:
0.450
show subpopulations
Gnomad AFR exome
AF:
0.373
Gnomad AMR exome
AF:
0.536
Gnomad ASJ exome
AF:
0.403
Gnomad EAS exome
AF:
0.641
Gnomad FIN exome
AF:
0.301
Gnomad NFE exome
AF:
0.418
Gnomad OTH exome
AF:
0.433
GnomAD4 exome
AF:
0.437
AC:
638619
AN:
1461370
Hom.:
142039
Cov.:
40
AF XY:
0.438
AC XY:
318707
AN XY:
727024
show subpopulations
African (AFR)
AF:
0.368
AC:
12319
AN:
33454
American (AMR)
AF:
0.535
AC:
23900
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.402
AC:
10508
AN:
26120
East Asian (EAS)
AF:
0.627
AC:
24879
AN:
39694
South Asian (SAS)
AF:
0.521
AC:
44949
AN:
86254
European-Finnish (FIN)
AF:
0.302
AC:
16131
AN:
53418
Middle Eastern (MID)
AF:
0.487
AC:
2811
AN:
5768
European-Non Finnish (NFE)
AF:
0.428
AC:
476289
AN:
1111596
Other (OTH)
AF:
0.444
AC:
26833
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
18741
37482
56222
74963
93704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14774
29548
44322
59096
73870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.418
AC:
63511
AN:
152006
Hom.:
13691
Cov.:
32
AF XY:
0.418
AC XY:
31042
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.375
AC:
15524
AN:
41452
American (AMR)
AF:
0.502
AC:
7672
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.414
AC:
1433
AN:
3464
East Asian (EAS)
AF:
0.641
AC:
3311
AN:
5162
South Asian (SAS)
AF:
0.518
AC:
2496
AN:
4822
European-Finnish (FIN)
AF:
0.291
AC:
3068
AN:
10558
Middle Eastern (MID)
AF:
0.422
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
0.421
AC:
28594
AN:
67966
Other (OTH)
AF:
0.418
AC:
881
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1869
3739
5608
7478
9347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
600
1200
1800
2400
3000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.415
Hom.:
7385
Bravo
AF:
0.429
Asia WGS
AF:
0.548
AC:
1900
AN:
3478
EpiCase
AF:
0.426
EpiControl
AF:
0.431

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.36
DANN
Benign
0.60
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2291101; hg19: chr3-1424718; COSMIC: COSV63173618; API